Basic Information
Myoview
17156-024
Regulatory Information
17156-024
NDA020372
C73594
December 12, 2022
USA
These highlights do not include all the information needed to use MYOVIEW safely and effectively. See full prescribing information for MYOVIEW. MYOVIEW (Kit for the preparation of technetium Tc99m tetrofosmin injection) for intravenous use Initial U.S. Approval: 1996
HUMAN PRESCRIPTION DRUG LABEL
12
Company Information
095263729
Active Ingredients
Stannous Chloride
Quantity: 0.03 mg in 1 1
Code: 1BQV3749L5
Class Code: IACT
Disodium Sulfosalicylate
Quantity: 0.32 mg in 1 1
Code: WFP6MAA96R
Class Code: IACT
Sodium Bicarbonate
Quantity: 1.8 mg in 1 1
Code: 8MDF5V39QO
Class Code: IACT
Active Moieties
Tetrofosmin
Code: 3J0KPB596Q